首頁 > 市場調查報告書 > 醫療設備

眼科設備

市場調查報告書

商品編碼

1441245

全球淚道裝置市場規模、佔有率、成長分析（按產品、按應用） - 產業預測，2023-2030 年

Global Lacrimal Devices Market Size, Share, Growth Analysis, By Product(Intubation Sets, Stents And Tubes), By Application(Glaucoma, Dry Eye) - Industry Forecast 2023-2030

出版日期: 2024年02月17日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球淚道裝置市場規模為2001.6億美元，預計將從2023年的 2,171.7 億美元成長到2031年的 4,171.1 億美元，預測期內（2024-2031年）年複合成長率為 8.5%。

由於不同年齡層對眼部疾病的認知和診斷不斷提高，淚道裝置市場顯著成長。

隨著眼部疾病的增加，對先進淚道裝置（如穿刺塞、淚道支架和沖洗系統）的需求不斷增加。此外，技術和手術方法的進步改善患者的治療效果並有助於市場的擴張。人口老化以及與老齡化相關的眼睛問題的相應增加也促進了市場的持續成長。醫療保健提供者和製造商積極致力於開發創新解決方案，以滿足淚液障礙患者不斷變化的需求，重點是提高護理品質和患者舒適度。監管因素和償付政策在塑造市場動態方面也發揮著重要作用。總體而言，淚道裝置市場為眼科裝置領域的公司提供了充滿希望的機會，越來越注重以患者為中心的解決方案和改善治療結果。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東、非洲
- 海灣合作理事會國家
- 南非
- 其他中東、非洲地區

競爭格局

前5名企業比較
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

FCI Ophthalmic（法國）
Kaneka Corporation（日本）
Lacrimedics, Inc.（美國）
Cook Group（美國）
BVI（英國）
Rumex International（美國）
Bess Medical Technology GmbH（德國）
Alcon（瑞士）
Bausch and Lomb Incorporated（美國）
BraunMelsungen AG（德國）
OASIS Medical, Inc.（美國）
Beaver-Visitec International（美國）
FC Optics Ltd.（以色列）
D.O.R.C. Dutch Ophthalmic Research Center（荷蘭）
OptiMedica Corporation（美國）
MicroSurgical Technology（美國）
Diamatrix Ltd.（英國）
FCI S.A.S.（法國）
Novartis AG（瑞士）
Eye Kon Medical, Inc.（美國）

簡介目錄

Product Code: SQMIG35G2212

Global Lacrimal Devices Market size was valued at USD 200.16 Billion in 2022 and is poised to grow from USD 217.17 Billion in 2023 to USD Billion 417.11 by 2031, at a CAGR of 8.5% during the forecast period (2024-2031).

The lacrimal devices market is experiencing substantial growth due to the rising awareness and diagnosis of ophthalmic conditions across various age demographics.

With an increase in eye-related disorders, there is a growing demand for advanced lacrimal devices such as punctual plugs, lacrimal stents, and irrigation systems. Furthermore, advancements in technology and surgical methods have resulted in better patient outcomes, contributing to the expansion of the market. The aging population and the corresponding rise in age-related eye issues also contribute to the market's sustained growth. Healthcare providers and manufacturers are actively working on developing innovative solutions to meet the evolving needs of patients with lacrimal disorders, with a focus on improving care quality and patient comfort. Regulatory factors and reimbursement policies also play a significant role in shaping the market's dynamics. Overall, the lacrimal devices market presents promising opportunities for companies in the ophthalmic devices sector, with an increasing emphasis on patient-centred solutions and enhanced treatment results.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lacrimal Devices and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Lacrimal Devices Market Segmental Analysis

The global lacrimal devices market is segmented on the basis of product, application and region. Based on product the market is segmented as intubation sets, stents and tubes, dilators. On the basis of application, the market is segmented as glaucoma, dry eye, and lacrimal gland inflammation. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Lacrimal Devices Market

The main factor fuelling the lacrimal devices market is the rising prevalence of eye disorders worldwide. Elements such as aging populations, shifting lifestyles, and increased screen usage lead to conditions such as dry eye syndrome and other lacrimal system disorders. This results in an increased need for lacrimal devices for diagnosing and treating these conditions, driving the growth of the market.

Restraints in the Global Lacrimal Devices Market

A significant challenge in the lacrimal devices sector is the strict regulatory environment and potential delays in obtaining approvals for new products or modifications. Regulatory bodies, especially in North America and Europe, have rigorous standards for medical devices, which can result in prolonged timelines for market introduction. These regulatory obstacles can hinder innovation and market expansion, affecting both established companies and new entrants in the field.

Market Trends of the Global Lacrimal Devices Market

A notable trend in the lacrimal devices market is the growing inclination towards minimally invasive procedures. Patients and healthcare providers are favouring less invasive methods for treating lacrimal system disorders due to their advantages, including faster recovery times, fewer postoperative complications, and enhanced patient comfort. This shift is spurring innovation in the creation of minimally invasive lacrimal devices, such as micro endoscopes and specialized catheters, to meet the changing preferences in patient care.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Lacrimal Devices Market by Product

Market Overview
Intubation Sets
Stents And Tubes
Dilators

Global Lacrimal Devices Market by Application

Market Overview
Glaucoma
Dry Eye
Lacrimal Gland Inflammation

Global Lacrimal Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

FCI Ophthalmic (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kaneka Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lacrimedics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Group (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BVI (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rumex International (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bess Medical Technology GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alcon (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bausch and Lomb Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BraunMelsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OASIS Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beaver-Visitec International (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FC Optics Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
D.O.R.C. Dutch Ophthalmic Research Center (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OptiMedica Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroSurgical Technology (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Diamatrix Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FCI S.A.S. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eye Kon Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments